Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects with Solid Tumors
foretinib
MET111648
NCT00743067
Solid Tumours
Phase 1
 
November 2015

Powered by ideaPoint, Inc.